Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, McGill University researchers report.
A new study published in iScience found lithium can prevent infected cells from reactivating, and that it does so through an unexpected biological mechanism.
The findings point toward future treatments designed to mimic lithium’s beneficial effects while avoiding its broader impacts on the body.







